Glaxo Smith Kline 58160081052 - Infanrix®… | USA MedPremium
Infanrix® DTaP Vaccine Indicated for People 6 Weeks to 7 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine, Adsorbed Injection Prefilled Syringe 0.5 mL
USAMP#30714489SKU: 58160081052Infanrix®
License Required
Product Spotlight
INFANRIX is a vaccine indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children 6 weeks to 7 years of age
Each 0.5-mL dose is formulated to contain 25 Lf of diphtheria toxoid, 10 Lf of tetanus toxoid, 25 mcg of inactivated pertussis toxin (PT), 25 mcg of filamentous hemagglutinin (FHA), and 8 mcg of pertactin (69 kiloDalton outer membrane protein)
Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)